Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1539127
PUBLISHER: KBV Research | PRODUCT CODE: 1539127
LAMEA Anxiety Disorders And Depression Treatment Market Size, Share & Trends Analysis Report By Indication (Anxiety and Depression) By Drugs, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031
PUBLISHED:
PAGES: 134 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa Anxiety Disorders And Depression Treatment Market would witness market growth of 5.8% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Anxiety Disorders And Depression Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $316.1 million by 2031. The Argentina market is showcasing a CAGR of 6.5% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 5.1% during (2024 - 2031).
Innovations in the treatment of anxiety disorders and depression are continually evolving to address the complex nature of these conditions. Advances in technology, research, and therapeutic approaches are driving significant improvements in how these mental health issues are managed.
Moreover, medications like ketamine and its derivative ketamine have emerged as rapid-acting antidepressants, offering relief from severe depression within hours or days rather than weeks. These treatments are particularly beneficial for individuals with treatment-resistant depression.
With growing mental health issues among children, there's a rising demand for specialized treatment services. This includes increased utilization of paediatric mental health professionals, child psychologists, and psychiatrists in the UAE. Depressive symptoms are experienced by approximately 17% to 22% of young people in the United Arab Emirates, as indicated by the International Health Policies. Depression and anxiety symptoms are reported by up to one-third of children with chronic disorders.
Based on Indication, the market is segmented into Anxiety and Depression. Based on Drugs, the market is segmented into Antidepressants, Anxiolytics, Anticonvulsants, Noradrenergic Agents, and Atypical Antipsychotics. Based on Distribution Channel, the market is segmented into Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
List of Key Companies Profiled
- Pfizer Inc.
- GlaxoSmithKline PLC (GSK)
- Merck & Co., Inc.
- Eli Lilly And Company
- AstraZeneca PLC
- Bristol-Myers Squibb Company
- Johnson & Johnson
- AbbVie Inc.
- Sanofi S.A.
- Takeda Pharmaceutical Company Limited
LAMEA Anxiety Disorders And Depression Treatment Market Report Segmentation
By Indication
- Anxiety
- Depression
By Drugs
- Antidepressants
- Anxiolytics
- Anticonvulsants
- Noradrenergic Agents
- Atypical Antipsychotics
By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA Anxiety Disorders And Depression Treatment Market, by Indication
- 1.4.2 LAMEA Anxiety Disorders And Depression Treatment Market, by Drugs
- 1.4.3 LAMEA Anxiety Disorders And Depression Treatment Market, by Distribution Channel
- 1.4.4 LAMEA Anxiety Disorders And Depression Treatment Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Anxiety Disorders And Depression Treatment Market by Indication
- 4.1 LAMEA Anxiety Market by Country
- 4.2 LAMEA Depression Market by Country
Chapter 5. LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
- 5.1 LAMEA Antidepressants Market by Country
- 5.2 LAMEA Anxiolytics Market by Country
- 5.3 LAMEA Anticonvulsants Market by Country
- 5.4 LAMEA Noradrenergic Agents Market by Country
- 5.5 LAMEA Atypical Antipsychotics Market by Country
Chapter 6. LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 6.1 LAMEA Retail Pharmacies Market by Country
- 6.2 LAMEA Hospital Pharmacies Market by Country
- 6.3 LAMEA Online Pharmacies Market by Country
Chapter 7. LAMEA Anxiety Disorders And Depression Treatment Market by Country
- 7.1 Brazil Anxiety Disorders And Depression Treatment Market
- 7.1.1 Brazil Anxiety Disorders And Depression Treatment Market by Indication
- 7.1.2 Brazil Anxiety Disorders And Depression Treatment Market by Drugs
- 7.1.3 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.2 Argentina Anxiety Disorders And Depression Treatment Market
- 7.2.1 Argentina Anxiety Disorders And Depression Treatment Market by Indication
- 7.2.2 Argentina Anxiety Disorders And Depression Treatment Market by Drugs
- 7.2.3 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.3 UAE Anxiety Disorders And Depression Treatment Market
- 7.3.1 UAE Anxiety Disorders And Depression Treatment Market by Indication
- 7.3.2 UAE Anxiety Disorders And Depression Treatment Market by Drugs
- 7.3.3 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.4 Saudi Arabia Anxiety Disorders And Depression Treatment Market
- 7.4.1 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication
- 7.4.2 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs
- 7.4.3 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.5 South Africa Anxiety Disorders And Depression Treatment Market
- 7.5.1 South Africa Anxiety Disorders And Depression Treatment Market by Indication
- 7.5.2 South Africa Anxiety Disorders And Depression Treatment Market by Drugs
- 7.5.3 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.6 Nigeria Anxiety Disorders And Depression Treatment Market
- 7.6.1 Nigeria Anxiety Disorders And Depression Treatment Market by Indication
- 7.6.2 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs
- 7.6.3 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel
- 7.7 Rest of LAMEA Anxiety Disorders And Depression Treatment Market
- 7.7.1 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication
- 7.7.2 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs
- 7.7.3 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel
Chapter 8. Company Profiles
- 8.1 Pfizer, Inc.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional & Segmental Analysis
- 8.1.4 Research & Development Expense
- 8.1.5 SWOT Analysis
- 8.2 GlaxoSmithKline PLC (GSK)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 SWOT Analysis
- 8.3 Merck & Co., Inc.
- 8.3.1 Company Overview
- 8.3.2 Financial Analysis
- 8.3.3 Segmental and Regional Analysis
- 8.3.4 Research & Development Expenses
- 8.3.5 SWOT Analysis
- 8.4 Eli Lilly And Company
- 8.4.1 Company Overview
- 8.4.2 Financial Analysis
- 8.4.3 Regional Analysis
- 8.4.4 Research & Development Expenses
- 8.4.5 SWOT Analysis
- 8.5 AstraZeneca PLC
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expenses
- 8.5.5 SWOT Analysis
- 8.6 Bristol-Myers Squibb Company
- 8.6.1 Company Overview
- 8.6.2 Financial Analysis
- 8.6.3 Regional Analysis
- 8.6.4 Research & Development Expenses
- 8.6.5 SWOT Analysis
- 8.7 Johnson & Johnson
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental & Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
- 8.8 AbbVie, Inc.
- 8.8.1 Company Overview
- 8.8.2 Financial Analysis
- 8.8.3 Regional Analysis
- 8.8.4 Research & Development Expense
- 8.8.5 SWOT Analysis
- 8.9 Sanofi S.A.
- 8.9.1 Company Overview
- 8.9.2 Financial Analysis
- 8.9.3 Segmental and Regional Analysis
- 8.9.4 Research & Development Expense
- 8.9.5 SWOT Analysis
- 8.10. Takeda Pharmaceutical Company Limited
- 8.10.1 Company Overview
- 8.10.2 Financial Analysis
- 8.10.3 Regional Analysis
- 8.10.4 Research & Development Expense
- 8.10.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 LAMEA Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 2 LAMEA Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 3 LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 4 LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 5 LAMEA Anxiety Market by Country, 2020 - 2023, USD Million
- TABLE 6 LAMEA Anxiety Market by Country, 2024 - 2031, USD Million
- TABLE 7 LAMEA Depression Market by Country, 2020 - 2023, USD Million
- TABLE 8 LAMEA Depression Market by Country, 2024 - 2031, USD Million
- TABLE 9 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 10 LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 11 LAMEA Antidepressants Market by Country, 2020 - 2023, USD Million
- TABLE 12 LAMEA Antidepressants Market by Country, 2024 - 2031, USD Million
- TABLE 13 LAMEA Anxiolytics Market by Country, 2020 - 2023, USD Million
- TABLE 14 LAMEA Anxiolytics Market by Country, 2024 - 2031, USD Million
- TABLE 15 LAMEA Anticonvulsants Market by Country, 2020 - 2023, USD Million
- TABLE 16 LAMEA Anticonvulsants Market by Country, 2024 - 2031, USD Million
- TABLE 17 LAMEA Noradrenergic Agents Market by Country, 2020 - 2023, USD Million
- TABLE 18 LAMEA Noradrenergic Agents Market by Country, 2024 - 2031, USD Million
- TABLE 19 LAMEA Atypical Antipsychotics Market by Country, 2020 - 2023, USD Million
- TABLE 20 LAMEA Atypical Antipsychotics Market by Country, 2024 - 2031, USD Million
- TABLE 21 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 22 LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 23 LAMEA Retail Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 24 LAMEA Retail Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 25 LAMEA Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 26 LAMEA Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 27 LAMEA Online Pharmacies Market by Country, 2020 - 2023, USD Million
- TABLE 28 LAMEA Online Pharmacies Market by Country, 2024 - 2031, USD Million
- TABLE 29 LAMEA Anxiety Disorders And Depression Treatment Market by Country, 2020 - 2023, USD Million
- TABLE 30 LAMEA Anxiety Disorders And Depression Treatment Market by Country, 2024 - 2031, USD Million
- TABLE 31 Brazil Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 32 Brazil Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 33 Brazil Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 34 Brazil Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 35 Brazil Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 36 Brazil Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 37 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 38 Brazil Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 39 Argentina Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 40 Argentina Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 41 Argentina Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 42 Argentina Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 43 Argentina Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 44 Argentina Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 45 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 46 Argentina Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 47 UAE Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 48 UAE Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 49 UAE Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 50 UAE Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 51 UAE Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 52 UAE Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 53 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 54 UAE Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 55 Saudi Arabia Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 56 Saudi Arabia Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 57 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 58 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 59 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 60 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 61 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 62 Saudi Arabia Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 63 South Africa Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 64 South Africa Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 65 South Africa Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 66 South Africa Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 67 South Africa Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 68 South Africa Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 69 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 70 South Africa Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 71 Nigeria Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 72 Nigeria Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 73 Nigeria Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 74 Nigeria Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 75 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 76 Nigeria Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 77 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 78 Nigeria Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 79 Rest of LAMEA Anxiety Disorders And Depression Treatment Market, 2020 - 2023, USD Million
- TABLE 80 Rest of LAMEA Anxiety Disorders And Depression Treatment Market, 2024 - 2031, USD Million
- TABLE 81 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2020 - 2023, USD Million
- TABLE 82 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Indication, 2024 - 2031, USD Million
- TABLE 83 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2020 - 2023, USD Million
- TABLE 84 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Drugs, 2024 - 2031, USD Million
- TABLE 85 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2020 - 2023, USD Million
- TABLE 86 Rest of LAMEA Anxiety Disorders And Depression Treatment Market by Distribution Channel, 2024 - 2031, USD Million
- TABLE 87 Key Information - Pfizer, Inc.
- TABLE 88 Key Information - GlaxoSmithKline PLC
- TABLE 89 Key Information - Merck & Co., Inc.
- TABLE 90 Key Information - Eli Lilly And Company
- TABLE 91 Key Information - AstraZeneca PLC
- TABLE 92 Key Information - Bristol-Myers Squibb Company
- TABLE 93 Key Information - Johnson & Johnson
- TABLE 94 Key information - AbbVie, Inc.
- TABLE 95 Key Information - Sanofi S.A.
- TABLE 96 Key Information - Takeda Pharmaceutical Company Limited
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.